355 related articles for article (PubMed ID: 30716086)
21. Pain-related behaviors and abnormal cutaneous innervation in a murine model of classical Ehlers-Danlos syndrome.
Syx D; Miller RE; Obeidat AM; Tran PB; Vroman R; Malfait Z; Miller RJ; Malfait F; Malfait AM
Pain; 2020 Oct; 161(10):2274-2283. PubMed ID: 32483055
[TBL] [Abstract][Full Text] [Related]
22. Bi-allelic AEBP1 mutations in two patients with Ehlers-Danlos syndrome.
Syx D; De Wandele I; Symoens S; De Rycke R; Hougrand O; Voermans N; De Paepe A; Malfait F
Hum Mol Genet; 2019 Jun; 28(11):1853-1864. PubMed ID: 30668708
[TBL] [Abstract][Full Text] [Related]
23. Bi-allelic Alterations in AEBP1 Lead to Defective Collagen Assembly and Connective Tissue Structure Resulting in a Variant of Ehlers-Danlos Syndrome.
Blackburn PR; Xu Z; Tumelty KE; Zhao RW; Monis WJ; Harris KG; Gass JM; Cousin MA; Boczek NJ; Mitkov MV; Cappel MA; Francomano CA; Parisi JE; Klee EW; Faqeih E; Alkuraya FS; Layne MD; McDonnell NB; Atwal PS
Am J Hum Genet; 2018 Apr; 102(4):696-705. PubMed ID: 29606302
[TBL] [Abstract][Full Text] [Related]
24. Molecular genetics in classic Ehlers-Danlos syndrome.
Malfait F; De Paepe A
Am J Med Genet C Semin Med Genet; 2005 Nov; 139C(1):17-23. PubMed ID: 16278879
[TBL] [Abstract][Full Text] [Related]
25. Multifaced Roles of the αvβ3 Integrin in Ehlers-Danlos and Arterial Tortuosity Syndromes' Dermal Fibroblasts.
Zoppi N; Chiarelli N; Ritelli M; Colombi M
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587413
[TBL] [Abstract][Full Text] [Related]
26. COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS.
Wenstrup RJ; Florer JB; Willing MC; Giunta C; Steinmann B; Young F; Susic M; Cole WG
Am J Hum Genet; 2000 Jun; 66(6):1766-76. PubMed ID: 10777716
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanisms of classical Ehlers-Danlos syndrome (EDS).
Mitchell AL; Schwarze U; Jennings JF; Byers PH
Hum Mutat; 2009 Jun; 30(6):995-1002. PubMed ID: 19370768
[TBL] [Abstract][Full Text] [Related]
28. Molecular alterations due to Col5a1 haploinsufficiency in a mouse model of classic Ehlers-Danlos syndrome.
Machol K; Polak U; Weisz-Hubshman M; Song IW; Chen S; Jiang MM; Chen-Evenson Y; Weis MAE; Keene DR; Eyre DR; Lee BH
Hum Mol Genet; 2022 Apr; 31(8):1325-1335. PubMed ID: 34740257
[TBL] [Abstract][Full Text] [Related]
29. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency.
Schalkwijk J; Zweers MC; Steijlen PM; Dean WB; Taylor G; van Vlijmen IM; van Haren B; Miller WL; Bristow J
N Engl J Med; 2001 Oct; 345(16):1167-75. PubMed ID: 11642233
[TBL] [Abstract][Full Text] [Related]
30. Expanding the Clinical and Mutational Spectrum of Recessive
Ritelli M; Cinquina V; Venturini M; Pezzaioli L; Formenti AM; Chiarelli N; Colombi M
Genes (Basel); 2019 Feb; 10(2):. PubMed ID: 30759870
[TBL] [Abstract][Full Text] [Related]
31. Transcriptome Profiling of Primary Skin Fibroblasts Reveal Distinct Molecular Features Between
Lim PJ; Lindert U; Opitz L; Hausser I; Rohrbach M; Giunta C
Genes (Basel); 2019 Jul; 10(7):. PubMed ID: 31288483
[TBL] [Abstract][Full Text] [Related]
32. An exon skipping mutation of a type V collagen gene (COL5A1) in Ehlers-Danlos syndrome.
Nicholls AC; Oliver JE; McCarron S; Harrison JB; Greenspan DS; Pope FM
J Med Genet; 1996 Nov; 33(11):940-6. PubMed ID: 8950675
[TBL] [Abstract][Full Text] [Related]
33. Clinical and genetic analysis of classical Ehlers-Danlos syndrome patient caused by synonymous mutation in COL5A2.
Ma N; Zhu Z; Liu J; Peng Y; Zhao X; Tang W; Jia Z; Xi H; Gao B; Wang H; Du J
Mol Genet Genomic Med; 2021 May; 9(5):e1632. PubMed ID: 33834621
[TBL] [Abstract][Full Text] [Related]
34. Aortic Dissection in a Patient with Novel Frameshift COL5A1 Variant of Classical Ehlers-Danlos Syndrome.
Caley L; Campar A; Mendonça T; Farinha F
Eur J Case Rep Intern Med; 2023; 10(2):003698. PubMed ID: 36970158
[TBL] [Abstract][Full Text] [Related]
35. COL5A1 exon 14 splice acceptor mutation causes a functional null allele, haploinsufficiency of alpha 1(V) and abnormal heterotypic interstitial fibrils in Ehlers-Danlos syndrome II.
Bouma P; Cabral WA; Cole WG; Marini JC
J Biol Chem; 2001 Apr; 276(16):13356-64. PubMed ID: 11278977
[TBL] [Abstract][Full Text] [Related]
36. Biological insights in the pathogenesis of hypermobile Ehlers-Danlos syndrome from proteome profiling of patients' dermal myofibroblasts.
Chiarelli N; Zoppi N; Ritelli M; Venturini M; Capitanio D; Gelfi C; Colombi M
Biochim Biophys Acta Mol Basis Dis; 2021 Apr; 1867(4):166051. PubMed ID: 33383104
[TBL] [Abstract][Full Text] [Related]
37. Skeletal muscle morphology, protein synthesis, and gene expression in Ehlers-Danlos syndrome.
Nygaard RH; Jensen JK; Voermans NC; Heinemeier KM; Schjerling P; Holm L; Agergaard J; Mackey AL; Andersen JL; Remvig L; Kjaer M
J Appl Physiol (1985); 2017 Aug; 123(2):482-488. PubMed ID: 28596275
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a patient with classical Ehlers-Danlos syndrome due to a 9q34 duplication affecting COL5A1.
Kuroda Y; Ohashi I; Naruto T; Ida K; Enomoto Y; Saito T; Nagai JI; Kurosawa K
Congenit Anom (Kyoto); 2018 Nov; 58(6):191-193. PubMed ID: 29520887
[TBL] [Abstract][Full Text] [Related]
39. Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha1(V) N-propeptides and Ehlers-Danlos syndrome type I.
Takahara K; Schwarze U; Imamura Y; Hoffman GG; Toriello H; Smith LT; Byers PH; Greenspan DS
Am J Hum Genet; 2002 Sep; 71(3):451-65. PubMed ID: 12145749
[TBL] [Abstract][Full Text] [Related]
40. COL5A1 signal peptide mutations interfere with protein secretion and cause classic Ehlers-Danlos syndrome.
Symoens S; Malfait F; Renard M; André J; Hausser I; Loeys B; Coucke P; De Paepe A
Hum Mutat; 2009 Feb; 30(2):E395-403. PubMed ID: 18972565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
